FoCUS Monthly Recap: September 2021

Eric NormanFoCUS, News


Self-Insured Employers Workshop shares practical advice for covering cell and gene therapies

In June FoCUS hosted a workshop for self-insured employers to help them understand the challenges and potential solutions presented by new cell and gene therapies. In our event archive you can see presentations framing the challenges and responses, as well as other discussions about stop loss coverage implications and emerging commercial solutions.

Visit the archive


Colin Young and Nikola Ivica published “Tracking the CAR-T Revolution: Analysis of Clinical Trials of CAR-T and TCR-T Therapies for the Treatment of Cancer (1997–2020)” in Healthcare on August 19. 

FoCUS work was referenced in a letter to the editors of Kaiser Health News in response to an article about the price and accessibility of new therapies

Jane Barlow spoke about the emerging market solutions for CGTs at the Huron Virtual Roundtable on September 22. On October 11 she will participate in the panel “Impact of Cell and Gene Therapy” at the 2021 Alliance for Innovation in Integrated Healthcare (AIIH) Summit in NYC, and on October 19 she and Michelle Harika will present “Addressing Gene Therapy Financial Challenges: A survey of emerging market solutions” at the AMCP Nexus 2021 in Denver

Mark Trusheim participated in the BCBSA 2021 Specialty Pharmacy Conference on July 20–21, and the World Orphan Drug Congress USA 2021 on August 25–27. 


The next FoCUS Design Lab will be held on October 13–14. By invitation only.